Simultaneous expression of RIPK1 and RIPK3 in the nucleus is an independent positive prognosticator for OS and PFS further underlining a potential positive effect of necroptosis in cervical cancer patients. This evidence concerns the gene RIPK3 and cervical carcinoma.